Skip to main content

Table 1 Initial homogeneity of sarcoptic mange parameters in study dogs

From: Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions

 

Oral fluralaner

(n = 54)

Topical fluralaner

(n = 46)

Oral sarolaner

(n = 26)

Initial mite counts

 Mean ± SD

9.6 ± 10.5

10.4 ± 14.3

10.3 ± 10.2

 Median

5.5

5.5

6.0

 Range

1–55

1–86

1–35

Initial pruritus scores

6.0 ± 2.4

5.0 ± 2.4

6.0 ± 2.8

 Mean ± SD

5.6 ± 2.4

5.1 ± 2.4

5.7 ± 2.8

 Median

6.0

5.0

6.0

 Range

2–9

0–10

2–10

Number of lesion areas

 Mean ± SD

5.1 ± 1.4

5.2 ± 1.2

5.3 ± 1.9

 Median

5.0

5.0

5.0

 Range

2–9

3–8

0–10

  1. Abbreviation: SD, standard deviation